PRESS RELEASE published on 03/10/2026 at 07:30, 6 months 24 days ago Evotec Announces ‘Horizon’ – Next Inflection in Its Strategic Transformation to Accelerate Growth and Promote Agility Evotec SE announces 'Horizon', the next phase in its strategic transformation to accelerate growth and promote agility through a new operating model across operations, science, and commercial execution Evotec SE Growth Strategic Transformation Horizon Operating Model
BRIEF published on 01/08/2026 at 07:35, 8 months 26 days ago Evotec Biologics obtient une subvention pour l'IA dans le développement d'anticorps monoclonaux Evotec SE Anticorps Monoclonaux Fondation Gates Optimisation Par IA Plateforme J.DESIGN™
BRIEF published on 01/08/2026 at 07:35, 8 months 26 days ago Just – Evotec Biologics Secures Grant for AI in Monoclonal Antibody Development Evotec SE AI Optimization Monoclonal Antibodies Gates Foundation J.DESIGN™ Platform
PRESS RELEASE published on 01/08/2026 at 07:30, 8 months 26 days ago Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access Just - Evotec Biologics, a subsidiary of Evotec SE, receives grant from Gates Foundation to optimize monoclonal antibody development using AI-driven molecular design, enhancing affordability and global access Evotec SE Grant Just - Evotec Biologics Gates Foundation Monoclonal Antibody
BRIEF published on 01/01/2026 at 07:35, 9 months 2 days ago Evotec Appoints Dr. Sarah Fakih as EVP of Global Communications and Investor Relations Investor Relations Leadership Communications Evotec Sarah Fakih
BRIEF published on 01/01/2026 at 07:35, 9 months 2 days ago Evotec nomme Sarah Fakih au poste de vice-présidente exécutive des communications mondiales et des relations avec les investisseurs. Direction Communications Relations Avec Les Investisseurs Evotec Sarah Fakih
PRESS RELEASE published on 01/01/2026 at 07:30, 9 months 2 days ago Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment Investor Relations Appointment Evotec Global Communications Dr. Sarah Fakih
BRIEF published on 12/08/2025 at 07:05, 9 months 26 days ago Evotec Finalizes Sale of Toulouse Site to Sandoz for $350 Million Revenue Growth Biosimilars Evotec Sandoz Technology License
BRIEF published on 12/08/2025 at 07:05, 9 months 26 days ago Evotec finalise la vente de son site de Toulouse à Sandoz pour 350 millions de dollars. Croissance Des Revenus Licence Technologique Evotec Biosimilaires Sandoz
PRESS RELEASE published on 12/08/2025 at 07:00, 9 months 26 days ago Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz Evotec closes sale of Just - Evotec Biologics' Toulouse site to Sandoz for over US$650m, including technology license fees. Sale improves revenue mix and profit margins Technology Sale Evotec Sandoz Biologics
Published on 10/03/2026 at 02:35, 13 hours 53 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 2 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 3 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 3 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 43 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 16 hours 33 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 20 hours 4 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 20 hours 42 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 21 hours 28 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 17:45, 22 hours 43 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 22 hours 43 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 22 hours 53 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 22 hours 58 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 22 hours 58 minutes ago Aéroports de Paris SA - Calendrier financier 2027